Concerns about a shipment
G protein-coupled receptor kinases
In its third-quarter results update this week, Novo Nordisk also revealed it has now filed for approval of oral semaglutide in the EU for launch in "selected markets," and sees the drug as "a big step forward in terms of expanding the market and for those individuals that align better with taking a pill for their obesity." Both companies have been investing heavily in direct-to-consumer (DTC) sales channels for cash purchasing of their current injectable products, and Novo Nordisk said on the call it will make oral semaglutide available across all its sales channels if approved.
She was telling us about how her breasts were not real and that she has, quote, 'she has no feeling in her nipples,' end quote, one staffer recounted
People who take semaglutide (the active ingredient in Ozempic and Wegovy) or tirzepatide (Mounjaro) frequently report: Nausea Vomiting Constipation or diarrhea Fatigue Headaches Decreased appetite These side effects can be uncomfortable, but theyre generally short-term and manageable for most patients
doi: 10.3390/microorganisms3040641